Lifecore Biomedical
United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
○ MHRA GMP
✓ HC GMP (9)
Quick Facts: Lifecore Biomedical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- United States
- Website
- https://www.lifecore.com/
- Modalities
- Sterile Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Lifecore Biomedical
Lifecore Biomedical is a contract development and manufacturing organization (CDMO). Capabilities: Sterile Fill-Finish. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.lifecore.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Lifecore Biomedical FDA Inspection History
2025-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-03-12 |
Lifecore Biomedical, LLC
Chaska, Minnesota
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Lifecore Biomedical FDA 483 Findings 2 observations · 2025-03-12 → 2025-03-12 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 1
- Repeat observations: 0
Most severe findings
-
Written program not followed
"The written stability testing program is not followed."
-
Cleaning / Sanitizing / Maintenance
"Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product."
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 2 articles
Company announcements, not verified evidence. They do not change any score.
Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing? - Yahoo Finance
Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing? Yahoo Finance
Lifecore Biomedical to Participate at Upcoming Industry Conferences - GlobeNewswire
Lifecore Biomedical to Participate at Upcoming Industry Conferences GlobeNewswire
Frequently Asked Questions About Lifecore Biomedical
How many FDA inspections does Lifecore Biomedical have on record?
CDMO Signal tracks 1 FDA inspection for Lifecore Biomedical, sourced from the FDA inspection database. See the full inspection history above.
Has Lifecore Biomedical received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Lifecore Biomedical.
Does Lifecore Biomedical have a CDMO Signal Score?
Not yet. Lifecore Biomedical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Lifecore Biomedical for a manufacturing program?
Use the free AI matchmaker to compare Lifecore Biomedical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
DPT Laboratories
San Antonio, Texas, United States
Semi-solids & Liquids, Non-sterile Liquids, Topicals, Finished Dosage Forms, Sterile Fill-Finish, Clinical Trial Manufacturing
Woodstock Sterile Solutions
United States
Sterile Fill-Finish
Sharp Services
United States
Packaging & Labeling, Sterile Fill-Finish
Vetio Animal Health
United States
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
503 Neo Lab (NeoLabs Pharma)
United States
Sterile Fill-Finish
Compare Lifecore Biomedical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.